MAGI2-AS3 was determined to be downregulated in leukemic stem cells and inhibited cell renewal by upregulating LRIG1, thereby improving the deterioration of acute myeloid leukemia [26]. The gene discussed is MAGI2; the disease is acute myeloid leukemia.